Home

Wyche Fowler

CIK 1301268 · last filed 2020-12-15

Wyche Fowler is a corporate insider who has filed 37 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $102.2K of BDN on Dec 15, 2020. Across all open-market trades the lifetime net is −$139.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $297.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$297.9K

Companies

3

Total Filings

37

Lifetime Open-Market Net

-$139.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BDN Director 75,689 $3.00 $227.1K -$132.9K 7 2020-12-15
Alaunos Therapeutics, Inc. (ZIOP) Delisted Director 163,328 $0.87 $141.4K $25.9K 20 2018-01-03
BMR Director 58,092 $1.22 $70.9K -$32.9K 10 2015-05-29

Recent Filings

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-12-15 BDN Sell (S) −8,598 -$102.2K EDGAR
2020-05-22 BDN Grant (A) +10,053 $0 EDGAR
2019-05-24 BDN Grant (A) +6,329 $0 EDGAR
2018-05-24 BDN Grant (A) +5,956 $0 EDGAR
2018-01-03 Alaunos Therapeutics, Inc. (ZIOP) Delisted Mixed +10,376 -$28.5K EDGAR
2017-12-13 Alaunos Therapeutics, Inc. (ZIOP) Delisted Mixed +4,200 -$11.8K EDGAR
2017-08-17 BDN Sell (S) −1,824 -$30.7K EDGAR
2017-06-14 Alaunos Therapeutics, Inc. (ZIOP) Delisted Mixed +1,020 -$3.7K EDGAR
2017-05-19 BDN Grant (A) +4,063 $0 EDGAR
2017-01-04 Alaunos Therapeutics, Inc. (ZIOP) Delisted Mixed +6,540 -$57.1K EDGAR
Showing 1–10 of 37
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.